scispace - formally typeset
A

Aamir Ahmad

Researcher at University of Alabama at Birmingham

Publications -  257
Citations -  15418

Aamir Ahmad is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Cancer & Cancer stem cell. The author has an hindex of 63, co-authored 251 publications receiving 13404 citations. Previous affiliations of Aamir Ahmad include Aligarh Muslim University & Hamad Medical Corporation.

Papers
More filters
Journal ArticleDOI

Perspectives on the role of isoflavones in prostate cancer.

TL;DR: A novel role of genistein and other isoflavones in the potentiation of radiation therapy, epigenetic regulation of key tumor suppressors and oncogenes, and the modulation of miRNAs, epithelial-to-mesenchymal transition, and cancer stem cells is indicated, which has renewed the interest of cancer researchers in this class of anticancer compounds.
Journal ArticleDOI

ETV4 Facilitates Cell-Cycle Progression in Pancreatic Cells through Transcriptional Regulation of Cyclin D1.

TL;DR: Mechanistic studies revealed that ETV4 directly regulates the expression of Cyclin D1 CCND1, a protein crucial for cell-cycle progression from G1- to S-phase, which provides the first experimental evidence for a functional role of ETV 4 in pancreatic cancer growth and cell- cycle progression.
Journal ArticleDOI

The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer.

TL;DR: Latest updates on the evidences that further highlight an association between various signaling pathways and EMT are provided, with a focus on therapeutic targets that may have the potential to reverse EMT.
Journal ArticleDOI

Differentially expressed miRNAs in cancer-stem-like cells: markers for tumor cell aggressiveness of pancreatic cancer

TL;DR: The results clearly suggest the importance of miRNAs in the regulation of CSLC characteristics, and may serve as novel targets for therapy.